Overview
The goal of this observational study is to document which LV-guidewires are used during a TAVI (Transcatheter Aortic Valve Implantation) procedure and how their different functions perform.
A TAVI procedure is a minimally invasive treatment for aortic stenosis, where a new heart valve is inserted through a blood vessel in the groin. During this procedure, a wire (specifically, an LV-guidewire) is used to place the new heart valve. For this purpose, a regular LV-guidewire or a newer LV-guidewire with extra features, the Savvywire, can be used. All of these wires work well, are safe, and are already used in daily medical practice. Researchers will compare these LV-guidewires to see if the Savvywire adds additional value.
Patients aged 50 or older who undergo a TAVI procedure via the femoral artery (blood vessel in the groin) can participate. Participants will receive the usual care and standard follow-up, only their data will be collected and analyzed.
Description
Patients are asked for consent after the TAVI procedure. Procedural data is therefore collected retrospectively, while standard follow-up data (3 months after the procedure) is collected prospectively.
Eligibility
Inclusion Criteria:
- Age ≥ 50 years
- Accepted for transfemoral TAVI procedure by Heart team and TAVI team
- Transfemoral TAVI procedure with balloon-expandable or self-expandable TAVI platform
- Ability to understand and the willingness to provide written informed consent
- Patients scheduled for valve-in-valve procedures can be included
- Patients with bicuspid anatomy can be included
Exclusion Criteria:
- Patients planned for a non-transfemoral TAVI procedure
- Extremely horizontal aorta (aortic root angle \>70 degrees)
- Extreme tortuosity at the level of the iliofemoral arteries, abdominal and/or thoracic aorta
- Inability to provide informed consent.
